- Home
- BLNE vs QNTM Comparison
BLNE vs QNTM Comparison
Compare BLNE & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLNE
- QNTM
- Stock Information
- Founded
- BLNE 2019
- QNTM 1998
- Country
- BLNE United States
- QNTM Canada
- Employees
- BLNE N/A
- QNTM N/A
- Industry
- BLNE
- QNTM
- Sector
- BLNE
- QNTM
- Exchange
- BLNE NYSE
- QNTM NYSE
- Market Cap
- BLNE 9.9M
- QNTM 8.7M
- IPO Year
- BLNE N/A
- QNTM N/A
- Fundamental
- Price
- BLNE $1.88
- QNTM $7.86
- Analyst Decision
- BLNE
- QNTM
- Analyst Count
- BLNE 0
- QNTM 0
- Target Price
- BLNE N/A
- QNTM N/A
- AVG Volume (30 Days)
- BLNE 2.4M
- QNTM 1.5M
- Earning Date
- BLNE 05-12-2025
- QNTM 05-13-2025
- Dividend Yield
- BLNE N/A
- QNTM N/A
- EPS Growth
- BLNE N/A
- QNTM N/A
- EPS
- BLNE N/A
- QNTM N/A
- Revenue
- BLNE N/A
- QNTM N/A
- Revenue This Year
- BLNE $231.61
- QNTM N/A
- Revenue Next Year
- BLNE $73.48
- QNTM N/A
- P/E Ratio
- BLNE N/A
- QNTM N/A
- Revenue Growth
- BLNE 81.73
- QNTM N/A
- 52 Week Low
- BLNE $1.43
- QNTM $2.70
- 52 Week High
- BLNE $29.80
- QNTM $44.20
- Technical
- Relative Strength Index (RSI)
- BLNE N/A
- QNTM 58.66
- Support Level
- BLNE N/A
- QNTM $6.45
- Resistance Level
- BLNE N/A
- QNTM $12.45
- Average True Range (ATR)
- BLNE 0.00
- QNTM 1.68
- MACD
- BLNE 0.00
- QNTM 0.23
- Stochastic Oscillator
- BLNE 0.00
- QNTM 35.97
About BLNE EASTSIDE DISTILLING INC
Beeline Holdings Inc is a technology-driven mortgage lender and title provider building a fully digital, AI-powered platform that simplifies and accelerates the home financing process.
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.